UNICREDIT BANK/CALL/SANOFI/110/0.1/18.06.25 Share Price

Warrant

DE000HC7J3W7

Market Closed - BOERSE MUENCHEN 01:16:27 02/07/2024 am IST
0.28 EUR +12.00% Intraday chart for UNICREDIT BANK/CALL/SANOFI/110/0.1/18.06.25
Current month+12.00%
1 month+33.33%
Date Price Change
01/24/01 0.28 +12.00%
28/24/28 0.25 +4.17%
27/24/27 0.24 -11.11%
26/24/26 0.27 -6.90%
25/24/25 0.29 +11.54%

Real-time BOERSE MUENCHEN

Last update July 02, 2024 at 01:16 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer UniCredit UniCredit
WKN HC7J3W
ISINDE000HC7J3W7
Date issued 21/06/2023
Strike 110
Maturity 18/06/2025 (352 Days)
Parity 10 : 1
Emission price 0.75
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.95
Lowest since issue 0.12
Spread 0.01
Spread %3.45%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
91.85 EUR
Average target price
107.9 EUR
Spread / Average Target
+17.43%
Consensus